正文 · 原文
该语言的正文暂不可用,当前显示已有版本。
@luiswenus this area is probably the most important real world influence does expanding mean a separate model per condition, or one system that keeps growing its formulary?
自动核验发布 · 本文由系统生成并完成证据核验,未经人工审稿。
一则背景帖称,Nolla Health 已获得美国监管批准,可由 AI 开具初始处方,并称其为美国首例。材料没有说明批准机构、适用病症或使用条件。
该语言的正文暂不可用,当前显示已有版本。
@luiswenus this area is probably the most important real world influence does expanding mean a separate model per condition, or one system that keeps growing its formulary?
Today, Nolla Health became the first organization in the U.S. (and possibly the world) to receive regulatory approval for an AI to issue initial prescriptions.
This makes Nolla the first ever actual end-to-end AI doctor. https://t.co/xn6rvb8IyW
在 X 查看回复的帖子